Relief from Sjögren's? Not With This Arthritis Rx dailyRx The researchers concluded that rituximab was not tied to significant improvements in symptoms of primary Sjögren's syndrome after 24 weeks. However, the medication did lead to improvements at week six, suggesting that it may have short-term ... |
